Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis by Harrison, C N, Vannucchi, A M, Kiladjian, J-J, Al-Ali, H K, Gisslinger, H, Knoops, L, Cervantes, F, Jones, M M, Sun, K, McQuitty, M, Stalbovskaya, V, Gopalakrishna, P, Barbui, T

Get full text

A pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase III trials of ruxolitinib for the treatment of myelofibrosis by Vannucchi, Alessandro M, Kantarjian, Hagop M, Kiladjian, Jean-Jacques, Gotlib, Jason, Cervantes, Francisco, Mesa, Ruben A, Sarlis, Nicholas J, Peng, Wei, Sandor, Victor, Gopalakrishna, Prashanth, Hmissi, Abdel, Stalbovskaya, Viktoriya, Gupta, Vikas, Harrison, Claire, Verstovsek, Srdan

Get full text

Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis by Harrison, C N, Vannucchi, A M, Kiladjian, J-J, Al-Ali, H K, Gisslinger, H, Knoops, L, Cervantes, F, Jones, M M, Sun, K, McQuitty, M, Stalbovskaya, V, Gopalakrishna, P, Barbui, T

Get full text

Erratum: Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis by Harrison, C N, Vannucchi, A M, Kiladjian, J-J, Al-Ali, H K, Gisslinger, H, Knoops, L, Cervantes, F, Jones, M M, Sun, K, McQuitty, M, Stalbovskaya, V, Gopalakrishna, P, Barbui, T

Get full text

MCLA-129, a human anti-EGFR and anti-c-MET bispecific antibody, in patients with advanced NSCLC and other solid tumors: an ongoing phase 1/2 study by Ou, S.H., Moreno Garcia, V., Gil Bazo, I., Prenen, H., Moreno, I., Johnson, M., Castañón Álvarez, E., Nagasaka, M., Adeyemi, S., Barasa, B., Bol, K., Doze, P., Engbers, A., Joe, A.K., Stalbovskaya, V., Laus, G., Call, J.

Get full text

Double-blind evaluation and benchmarking of survival models in a multi-centre study by Taktak, A, Antolini, L, Aung, M, Boracchi, P, Campbell, I, Damato, B, Ifeachor, E, Lama, N, Lisboa, P, Setzkorn, C, Stalbovskaya, V, Biganzoli, E

Get full text

A New Method for Modeling Preoperative Diagnosis of Ovarian Tumors by Stalbovskaya, Viktoriya, Ifeachor, Emmanuel C., Van Huffel, Sabine, Timmerman, Dirk

Get full text

Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study by Guglielmelli, Paola, Biamonte, Flavia, Rotunno, Giada, Artusi, Valentina, Artuso, Lucia, Bernardis, Isabella, Tenedini, Elena, Pieri, Lisa, Paoli, Chiara, Mannarelli, Carmela, Fjerza, Rajmonda, Rumi, Elisa, Stalbovskaya, Viktoriya, Squires, Matthew, Cazzola, Mario, Manfredini, Rossella, Harrison, Claire, Tagliafico, Enrico, Vannucchi, Alessandro M.

Get full text

Opposite effects of dexamethasone on antitumor and natural suppressor activities of bone marrow cells by Bel'skaya, N V, Stal'bovskaya, E S, Bel'skii, Y P, Agafonov, V I

Get full text

Suppressive and antitumor activities of bone marrow cells and splenocytes of AKR mice during aging by Bel'skii, Yu. P., Bel'skaya, N. V., Danilets, M. G., Stal'bovskaya, E. S., Kusmartsev, S. A.

Get full text

Role of interferon-γ in regulation of antiproliferative activity of bone marrow nonadherent cells by Bel'skii, Yu. P., Danilets, M. G., Bel'skaya, N. V., Stal'bovskaya, E. S., Kusmartsev, S. A.

Get full text

Role of interferon-[gamma] in regulation of antiproliferative activity of bone marrow nonadherent cells by Bel'skii, Yu P, Danilets, M G, Bel'skaya, N V, Stal'bovskaya, E S, Kusmartsev, S A

Get full text